Assessments of the immune blockade response to 3 checkpoints (PDCD1, CD274, and PDCD1LG2) and the IC50 for 2 classical antitumor drugs were conducted for glioma samples with varying SOCS1 expression levels in the CGGA and TCGA databases. This evidence concerns the gene SOCS1 and glioma.